Ambalal Sarabhai Enterprises gets nod to enter into SPA with Asence Pharma

27 Nov 2020 Evaluate

Ambalal Sarabhai Enterprises has received approval to enter into Share Purchase Agreement (SPA) with Asence Pharma for sale of 120446 (35,000 equity shares of face value of Rs 1000 each Rs 100 paid up, and 85,446 equity shares of face value of Rs 1000 each Rs 1000 paid up aggregating 120,446 equity shares) equity shares of Synbiotics, a wholly owned subsidiary to Asence Pharma, another subsidiary of the Company on consideration of Rs 11,91,87,640.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

38.88 -0.15 (-0.38%)
16-Apr-2025 15:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.65
Dr. Reddys Lab 1159.50
Cipla 1499.40
Lupin 1935.80
Zydus Lifesciences 822.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...